Colgate-Palmolive Company (NYSE:CL) is expected to pay $0.39 on Nov 15, 2016. The indicated annual dividend is $1.56. Shareholders owning the stock before Oct 20, 2016 will be eligible to receive the payout. Based on Colgate-Palmolive Company’s current price of $71.93, the dividend is 0.54%. This dividend’s record date is Oct 24, 2016 and the announcement date is Sep 9, 2016. The stock decreased 0.21% or $0.15 during the last trading session, hitting $71.93. Colgate-Palmolive Company (NYSE:CL) has risen 4.73% since March 16, 2016 and is uptrending. It has underperformed by 0.81% the S&P500.
Colgate-Palmolive Company is a consumer products company, whose products are marketed in over 200 countries and territories throughout the world. The company has a market cap of $63.92 billion. The Company’s divisions include Oral, Personal and Home Care, and Pet Nutrition. It has a 46.48 P/E ratio. The Oral, Personal and Home Care product segment is operated through over five geographic divisions, which include North America, Latin America, Europe/South Pacific, Asia and Africa/Eurasia.
Insitutional Activity: The institutional sentiment decreased to 0.87 in 2016 Q2. Its down 0.04, from 0.91 in 2016Q1. The ratio fall, as 47 funds sold all Colgate-Palmolive Company shares owned while 440 reduced positions. 53 funds bought stakes while 371 increased positions. They now own 618.55 million shares or 5.94% less from 657.64 million shares in 2016Q1.
Teachers Retirement System Of The State Of Kentucky holds 0.11% or 115,000 shares in its portfolio. Rockefeller Serv holds 355,901 shares or 0.52% of its portfolio. Hyman Charles D accumulated 72,033 shares or 0.79% of the stock. Proshare Advsrs Ltd holds 673,414 shares or 0.63% of its portfolio. Glenview Bank Tru Dept has 3,624 shares for 0.15% of their US portfolio. Moreover, Hartford Mngmt has 0.34% invested in Colgate-Palmolive Company (NYSE:CL) for 218,931 shares. Moreover, A D Beadell Counsel has 0.93% invested in Colgate-Palmolive Company (NYSE:CL) for 15,551 shares. Palisade Asset Lc holds 101,781 shares or 1.41% of its portfolio. Bancorpsouth has invested 0.05% of its portfolio in Colgate-Palmolive Company (NYSE:CL). Altavista Wealth Management has 3,741 shares for 0.15% of their US portfolio. Jensen Management has 139,767 shares for 0.16% of their US portfolio. Finance Mgmt reported 1,000 shares or 0.04% of all its holdings. Advisor Prtn Llc holds 13,241 shares or 0.34% of its portfolio. The New York-based Fieldpoint Private Advisors Inc has invested 2.18% in Colgate-Palmolive Company (NYSE:CL). Nordea Investment Mgmt last reported 115,320 shares in the company.
Insider Transactions: Since May 3, 2016, the stock had 0 insider purchases, and 17 insider sales for $21.98 million net activity. Wallace Noel R. also sold $643,598 worth of Colgate-Palmolive Company (NYSE:CL) shares. Verduin Patricia sold 3,666 shares worth $264,649. $1.13M worth of shares were sold by MOISON FRANCK J on Thursday, August 11. SADOVE STEPHEN I also sold $653,927 worth of Colgate-Palmolive Company (NYSE:CL) on Monday, August 8. 8,000 shares were sold by KOGAN RICHARD J, worth $597,254. HANCOCK ELLEN M sold $342,954 worth of stock. Another trade for 89,200 shares valued at $6.44 million was sold by Skala Justin.
Colgate-Palmolive Company (NYSE:CL) Ratings Coverage
Out of 16 analysts covering Colgate-Palmolive (NYSE:CL), 3 rate it a “Buy”, 0 “Sell”, while 13 “Hold”. This means 19% are positive. $88 is the highest target while $65 is the lowest. The $72.54 average target is 0.85% above today’s ($71.93) stock price. Colgate-Palmolive has been the topic of 27 analyst reports since July 21, 2015 according to StockzIntelligence Inc. As per Friday, September 4, the company rating was upgraded by Zacks. The rating was initiated by Sterne Agee CRT on Tuesday, July 21 with “Buy”. The firm earned “Buy” rating on Monday, September 12 by Bank of America. As per Monday, November 2, the company rating was maintained by S&P Research. As per Monday, January 18, the company rating was upgraded by BNP Paribas. The firm has “Sector Perform” rating given on Monday, January 4 by RBC Capital Markets. The company was maintained on Friday, April 29 by UBS. UBS maintained it with “Neutral” rating and $72 target price in Friday, July 31 report. UBS maintained it with “Neutral” rating and $78 target price in Friday, July 29 report. Barclays Capital maintained Colgate-Palmolive Company (NYSE:CL) rating on Monday, March 21. Barclays Capital has “Equal-Weight” rating and $70 price target.
CL Company Profile
Colgate-Palmolive Company (Colgate), incorporated on July 25, 1923, is a consumer products company, whose products are marketed in over 200 countries and territories throughout the world. The Firm operates in two product divisions: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through over five geographic divisions, which include North America, Latin America, Europe/South Pacific, Asia and Africa/Eurasia. The Company’s oral care products include Colgate Total; Colgate Sensitive Pro-Relief; Colgate Max Fresh; Colgate Maximum Cavity Protection with Sugar Acid Neutralizer; Colgate Optic White and Colgate Luminous White toothpastes, and Colgate Optic White, Colgate Total and Colgate Plax mouthwashes. Colgate’s Oral Care business also includes pharmaceutical products for dentists and other oral health professionals. The Firm sells its personal care products under the Palmolive, Protex and Softsoap brands. The Company, through its Hill’s Pet Nutrition segment (Hill’s), makes pet nutrition products for dogs and cats with products marketed in over 80 countries across the world.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.